Femasys Collaborates With AMI Technologies To Roll Out, Commercialize Fertility Portfolio In Israel
Benzinga Newsdesk 6 months ago
News
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today a strategic
Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today a strategic partnership with AMI Technologies to introduce and commercialize its fertility portfolio in Israel. This collaboration marks an important step in the Company's global expansion strategy and is expected to broaden international market access and drive adoption of innovative technologies, including FemaSeed as a first-line infertility treatment and FemVue® for ultrasound diagnosis of tubal factors.